Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Ischemic preconditioning: Interruption of various disorders.

Ahsas Goyal¹, Neetu Agrawal¹

¹Institute of Pharmaceutical Research, GLA University, Mathura 281406, U.P., India.

Journal of the Saudi Heart Association

|April 5, 2017

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Battling Parkinson's and Alzheimer's: The Neuroprotective Power of Carnosic Acid.

Journal of biochemical and molecular toxicology·2026

Same author

NLRP3 inflammasome: A key player in cardiac fibroblast to myofibroblast transition.

Pathology, research and practice·2026

Same author

Decoding the Role of Nutrition and Foods in Augmenting Athletes Performance: A Review.

Current drug research reviews·2026

Same author

Autophagy decline during ageing: Molecular regulation, tissue specificity, and therapeutic potential.

Pathology, research and practice·2026

Same author

Large scale multi-class pest image classification using structurally adapted DenseNet architecture.

Scientific reports·2026

Same author

Electrochemical microRNA biosensors for gallbladder cancer: Translational perspectives for clinical chemistry and point-of-care diagnostics.

Clinica chimica acta; international journal of clinical chemistry·2026

Same journal

Intermittent Fasting in Chronic Heart Failure: A Systematic Review of Safety and Physiological Outcomes.

Journal of the Saudi Heart Association·2026

Same journal

Right Ventricular-Pulmonary Artery Coupling Predicts Early Myocardial Strain Improvement in SGLT2 Inhibitor-Treated HFrEF.

Journal of the Saudi Heart Association·2026

Same journal

Comments on the Letter "Bridging the Gap: The Critical Next Steps for Implementing Genetic Risk Scores in Myocardial Infarction Prevention in Saudi Arabia".

Journal of the Saudi Heart Association·2026

Same journal

Bridging the Gap: The Critical Next Steps for Implementing Genetic Risk Scores in Myocardial Infarction Prevention in Saudi Arabia.

Journal of the Saudi Heart Association·2026

Same journal

Intravenous Atropine in Reducing Reperfusion Arrhythmias, Conduction Abnormalities, and Hypotension in Inferior ST-elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.

Journal of the Saudi Heart Association·2026

Same journal

Advancing Lipid Management: Saudi Heart Association Position Statement on PCSK9-targeted Therapies in the Primary and Secondary Prevention of Cardiovascular Disease.

Journal of the Saudi Heart Association·2026

See all related articles

Ischemic preconditioning protects the heart, but menopause and metabolic disorders like diabetes may reduce its effectiveness. Understanding these effects is crucial for treating heart ischemia.

Area of Science:

Cardiovascular Medicine
Pathophysiology
Molecular Cardiology

Background:

Ischemic heart diseases represent a major global health burden.
Myocardial ischemia-reperfusion injury occurs upon restoring blood flow to the heart.
Ischemic preconditioning is a protective strategy involving brief ischemia/reperfusion cycles.

Purpose of the Study:

To review how menopause affects myocardial ischemic preconditioning.
To investigate the impact of diabetes and hyperlipidemia on ischemic preconditioning.
To explore the underlying mechanisms of these modulatory effects.

Main Methods:

Literature review of existing research.
Analysis of studies on menopause, diabetes, and hyperlipidemia in cardiovascular contexts.

Keywords:

Diabetes Hyperlipidemia Ischemic preconditioning Menopause

Related Experiment Videos

Synthesis of mechanistic insights into preconditioning modulation.

Main Results:

Menopause can attenuate the cardioprotective effects of ischemic preconditioning.
Metabolic disorders like diabetes and hyperlipidemia also impair preconditioning efficacy.
Specific molecular pathways are implicated in these detrimental effects.

Conclusions:

Cardioprotection via ischemic preconditioning is compromised in specific physiological and pathological states.
Further research is needed to develop strategies to restore preconditioning benefits in affected populations.
Understanding these interactions is vital for improving patient outcomes in ischemic heart disease.